Global control of Covid-19
Good vaccines may not suffice
Bibliographic Data
| ID | 14965246 |
|---|---|
| Authors | Javier Eslava-Schmalbach (0000-0003-1502-2918, Universidad Nacional de Colombia, Bogotá, Colombia, corresponding author), Eric B Rosero (University of Texas Southwestern Medical Center, Dallas, Texas, United States of America), Nathaly Garzón-Orjuela (Universidad Nacional de Colombia, Bogotá, Colombia) |
| Year | 2021 |
| Volume | 45 |
| Pages | 1 |
| Publication date | 2021-12-10 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Revista Panamericana de Salud Pública (JOURNAL) |
| Journal identifiers | ISSN: 1020-4989 • E-ISSN: 1680-5348 |
| Publisher | Pan American Health Organization (PUBLISHER • US) |
| DOI | 10.26633/rpsp.2021.148 |
| PMID | 34908811 |
| OpenAlex | W4200049248 |
| Language | EN |
| References cited | 34 |
The COVID-19 pandemic has unveiled health and socioeconomic inequities around the globe. Effective epidemic control requires the achievement of herd immunity, where susceptible individuals are conferred indirect protection by being surrounded by immunized individuals. The proportion of people that need to be vaccinated to obtain herd immunity is determined through the herd immunity threshold. However, the number of susceptible individuals and the opportunities for contact between infectious and susceptible individuals influence the progress of an epidemic. Thus, in addition to vaccination, control of a pandemic may be difficult or impossible to achieve without other public health measures, including wearing face masks and social distancing. This article discusses the factors that may contribute to herd immunity and control of COVID-19 through the availability of effective vaccines and describes how vaccine effectiveness in the community may be lower than that expected. It also discusses how pandemic control in some countries and populations may face vaccine accessibility barriers if market forces strongly regulate the new technologies available, according to the inverse care law
Control (management · Coronavirus disease 2019 (COVID-19 · Herd · Herd immunity · Immunity · Pandemic · Public health · Socioeconomic status · COVID-19 Digital Contact Tracing · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy
Infectious Diseases of Humans
Covid-19 vaccine hesitancy in a representative working-age population in France
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Explaining trends in inequities
"Herd Immunity"
The Inverse Care Law
Racial Capitalism
Addressing Justified Vaccine Hesitancy in the Black Community
Coronavirus Vaccine Distribution
Covid-19 vaccines and treatments nationalism
| Citation velocity | historical |
|---|---|
| Highly cited | No |